Bioiberica has followed a vertical integration strategy in the last three years towards the development and sale of finished products. All products undergo scientific and clinical development and have their own marketing strategy to support sales in each country.
Bioiberica is going to held during 2010 in the three most important international conferences on diseases of the musculoskeletal system: those organized by EULAR, OARSI and ACR
In 2009 Bioiberica will have participated in the 3 most important international rheumatology conferences, as well as several scientific conferences on sports medicine and nutrition:
Since Bioiberica was founded in 1975, Heparin has been one of the companys most important products.
Bioiberica has created a New Technologies Division with the aim of addressing the needs of all patients suffering from chondral pathologies, while taking a further step away from conventional therapy towards more specific, personalized and effective treatments for every patient.